A Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke (LAS-2)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a cluster randomized controlled trial in which client-centered rehabilitation of activities of daily living (CADL) will be compared to usual rehabilitation of activities of daily living (UADL) regarding participation in activities of daily living, independence in activities of daily living and life satisfaction during the first year after stroke. In addition use of health services, caregiver burden and significant others' life satisfaction will be studied. Study design, methods and power analysis are based on our previous pilot study. Participating rehabilitation centers in the counties of Stockholm, Uppsala and Gavleborg have been randomized to supply CADL or UADL. Patients are included who are: < 3 months after stroke, dependent in at least two activities of daily living, understand instructions and referred to a participating rehabilitation unit. Data are collected at baseline, 3, 6 and 12 months. For sufficient power 280 participants will be included. In addition qualitative longitudinal studies will be performed in order to describe how CADL is integrated.
| Condition | Intervention |
|---|---|
|
Stroke Physical Disability Multiple Disability |
Behavioral: Client-centered ADL intervention Behavioral: Usual ADL intervention |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Health Services Research |
| Official Title: | A Randomized Controlled Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke |
- Perceived participation [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- Life satisfaction [ Time Frame: 3 and 12 months ] [ Designated as safety issue: No ]
- Utilization of health care and health related services [ Time Frame: During one year after inclusion ] [ Designated as safety issue: No ]
- Fatigue [ Time Frame: baseline, 3, 6 and 12 months ] [ Designated as safety issue: No ]
- Caregiver burden [ Time Frame: 3 and 12 months ] [ Designated as safety issue: No ]
- Self rated impact of stroke [ Time Frame: 3, 6 and 12 months ] [ Designated as safety issue: No ]Stroke Impact Scale
- Activities of daily living [ Time Frame: baseline, 3, 6 and 12 months ] [ Designated as safety issue: No ]
- Satisfaction with care [ Time Frame: 3, 6 and 12 months ] [ Designated as safety issue: No ]
| Enrollment: | 280 |
| Study Start Date: | September 2009 |
| Study Completion Date: | December 2012 |
| Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
-
Behavioral: Client-centered ADL intervention
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- < 3 months after stroke
- Dependent in at least two activities of daily living
- Able to understand instructions
- Referred to a participating rehabilitation unit.
Exclusion Criteria:
- Diagnosed dementia
Contacts and Locations| Sweden | |
| Karolinska Institutet | |
| Stockholm, Sweden | |
| Study Chair: | Kerstin Tham, PhD | Karolinska Institutet |
More Information
No publications provided
| Responsible Party: | Lena von Koch, Professor, Karolinska Institutet |
| ClinicalTrials.gov Identifier: | NCT01417585 History of Changes |
| Other Study ID Numbers: | 2009/727-31/1 |
| Study First Received: | August 15, 2011 |
| Last Updated: | April 14, 2013 |
| Health Authority: | Sweden: Regional Ethical Review Board Sweden: Swedish Research Council |
Keywords provided by Karolinska Institutet:
|
Activities of daily living Caregiver burden Client centered Life satisfaction Participation |
Patient satisfaction Rehabilitation Self rated impact of stroke Stroke |
Additional relevant MeSH terms:
|
Stroke Cerebral Infarction Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases Brain Infarction Brain Ischemia |
ClinicalTrials.gov processed this record on June 18, 2013